HYPERA S/A — Investor Relations & Filings

Hypera S/A, operating as Hypera Pharma, is a diversified pharmaceutical organization specializing in the development, production, and marketing of a broad spectrum of healthcare products. The company maintains a significant presence across multiple segments, including prescription drugs, over-the-counter (OTC) medicines, generics, and specialty pharmaceuticals. Its portfolio extends into consumer healthcare, biotechnology, dermocosmetics, and vitamin supplements. Key product lines include sweeteners under brands such as Adocyl, Finn, and Zero-cal, alongside various analgesics and health-related consumer goods. Hypera focuses on high-growth areas within the retail pharmaceutical market, leveraging a robust brand portfolio and integrated manufacturing capabilities to provide comprehensive therapeutic solutions. The company is characterized by its strategic emphasis on research and development in biotechnology and specialty medicine.